The interaction between smoking and CYP1A1 MspI polymorphism on lung cancer: a meta-analysis in the Chinese population

Abstract

Many studies have examined the interaction between CYP1A1 MspI gene polymorphism and smoking for the risk of lung cancer risk in Chinese, but their results have been inconsistent. Therefore, a meta-analysis was performed to ascertain this issue. PubMed, Springer Link, Ovid and other Chinese databases were searched to include all the relevant studies. Smoking status was categorised as 'smokers' and 'non-smokers.' The pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using fixed or random effect model. Subgroup analyses according to ethnicity, source of control and geographical location were also conducted. This meta-analysis identified 13 studies containing 2248 lung cases and 3079 controls. Overall, a significant association between lung cancer and the variants of CYP1A1 MspI was found among smokers (type B and type C combined vs. type A: OR = 1.89, 95% CI = 1.15-3.11, P = 0.000 for heterogeneity), whereas not found among non-smokers. Similar to the overall results, stratified analyses showed that the increased risk of lung cancer was observed in population-based studies and north China among smokers (OR = 1.65, 95%CI = 1.03-2.66; OR = 2.00, 95% CI = 1.14-3.53). Our meta-analysis showed that there was an interaction between the CYP1A1 MspI and smoking on the risk of lung cancer in the Chinese population.

Smoking and the Risk of Pneumonia: Research on the Impact of Tobacco on the Immune System of the Respiratory System

“…Smoking is an important risk factor for the occurrence of lung cancer. The age at which smoking starts, the daily amount of smoking, the depth of smoking, the duration of smoking, the total amount of smoking, and the time of smoking cessation are all related to the risk of developing lung cancer [8] . Studies have shown that the proportion of men among lung cancer smokers is higher, and the most common pathological type is squamous cell carcinoma, often accompanied by chronic airway inflammation.…”

Role of ERCC5 polymorphisms in non‑small cell lung cancer risk and responsiveness/toxicity to cisplatin‑based chemotherapy in the Chinese population

“…In China, the prevalence of NSCLC has been increasing rapidly in the past few decades, and it is reported that 652,842 new patients were diagnosed in 2012 (2). A large number of epidemiological studies have confirmed that environmental factors, especially tobacco smoking and heavy alcohol drinking are associated with the risk of NSCLC (3,4). Recently, an increasing amount of studies have revealed that hereditary factors play a crucial role in susceptibility to NSCLC (5,6).…”